SGLT2 Inhibitors and HF Outcomes Across Patient Populations SGLT2 Inhibitors and HF Outcomes Across Patient Populations

This brief paper summarizes recent trials on the efficacy of SGLT2 inhibitors in heart failure patients with diabetes, chronic kidney disease, HFrEF, HFpEF, and worsening HF.European Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news